Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-10 | Sold | €3.50 | +360.5% |
| 2026-10-10 | List | €11.94 | — |
| 2026-09-13 | Sold | €0.76 | — |
| 2026-09-12 | Sold | €0.76 | — |
| 2026-09-12 | List | €11.94 | +34.5% |
| 2026-09-11 | Sold | €0.76 | — |
| 2026-09-10 | Sold | €0.76 | — |
| 2026-09-10 | List | €8.88 | — |
| 2026-09-09 | List | €8.88 | — |
| 2026-09-08 | Sold | €0.76 | — |
| 2026-09-08 | List | €8.88 | — |
| 2026-09-07 | List | €8.88 | — |
| 2026-09-06 | Sold | €0.76 | — |
| 2026-09-06 | List | €8.88 | -25.6% |
Facing a New Trial / #022
Italy: lowest · Spain: above average · EU average €30.96Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €3.50 | €3.88 | €3.50 | +360.5% | >5 | |
NMRAW | €3.50 | €3.88 | €3.50 | +360.5% | >5 |
Explore Slowpoke (sm2+ 022) Facing a New Trial JP #022, Normal from Facing a New Trial, with 142 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.